Sarissa Capital Management’s Merck MRK Stock Holding History

Sarissa Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-419,200	Closed	-$19.8M	–	20
2015 Q3	$19.8M	Hold	419,200	–	–	4.88%	7
2015 Q2	$22.8M	Hold	419,200	–	–	5.24%	7
2015 Q1	$23M	Hold	419,200	–	–	4.85%	7
2014 Q4	$22.7M	Hold	419,200	–	–	8.04%	4
2014 Q3	$23.7M	Hold	419,200	–	–	9.16%	5
2014 Q2	$23.1M	Hold	419,200	–	–	7.87%	5
2014 Q1	$22.7M	Hold	419,200	–	–	7.82%	5
2013 Q4	$20M	Buy	+419,200	New	+$19.2M	7.5%	5

Other funds holding MRK

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sarissa Capital Management's MRK Position: Q4 2015 in Review

Sarissa Capital Management sold out of Merck (MRK) in Q4 2015, closing a stake of 419,200 shares — an estimated $19.8M sold.

Sarissa Capital Management first reported a position in MRK in Q4 2013 and held it in 8 quarters. The position peaked at $23.7M in Q3 2014. 1,755 funds tracked by Wall St. Rank hold MRK as of Q4 2015.

Sarissa Capital Management reported no remaining Merck position as of Q4 2015 after selling out during the quarter.
Sarissa Capital Management sold 419,200 Merck shares in Q4 2015, an estimated $19.8M.
Sarissa Capital Management first reported a position in Merck in Q4 2013 and held it in 8 quarters.
Sarissa Capital Management's Merck position peaked at $23.7M in Q3 2014.
1,755 funds tracked by Wall St. Rank held Merck as of Q4 2015.

Based on Sarissa Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.